<DOC>
	<DOCNO>NCT01976390</DOCNO>
	<brief_summary>This study do compare effectiveness safety two different kidney transplant immunosuppression drug , Zortress ( study drug ) Rapamune ( use current standard immunosuppression regimen ) .</brief_summary>
	<brief_title>Comparing Everolimus Sirolimus Renal Transplant Recipients</brief_title>
	<detailed_description>Zortress FDA approve , use standard care institution , may also give standard care believe best immunosuppression regimen particular kidney transplant recipient . The rationale testing Zortress vs. Rapamune determine drug effective prevent chronic rejection transplant kidney . Because two drug related current literature address replacement Rapamune Zortress immunosuppression regimen , therefore goal study compare two immunosuppression drug .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>1 . Patients must give write informed consent assessment perform . 2 . Primary renal transplant recipient age 18 75 year age . 3 . Females capable become pregnant must negative pregnancy test prior transplantation practice effective form birth control duration study 12 week discontinuation study drug applicable . 1 . Total cholesterol &gt; 300 mg/dl triglyceride &gt; 400 mg/dl despite lipid lower therapy 2 . Preexisting bone marrow suppression ( White Blood Cell count &lt; 3000 , platelets &lt; 100,000 ) 3 . Active infection ( Hepatitis B Virus , HIV ) 4 . Malignancy ( except adequately treat squamous basal cell skin carcinoma ) unless patient write clearance Oncologist patient malignancy least 2 year prior transplant 5 . Allergy intolerance Zortress , Rapamune , cyclosporine , Antithymocyte globulin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Kidney</keyword>
	<keyword>Kidney transplant</keyword>
	<keyword>Renal failure</keyword>
	<keyword>End Stage Renal Disease</keyword>
	<keyword>kidney transplant recipient</keyword>
</DOC>